Tag : Ibrutinib

Pharma / Biotech

Simultaneous measurement of acalabrutinib, ibrutinib, and their metabolites in beagle dog plasma by UPLC-MS/MS and its application to a pharmacokinetic study.

Newsemia
Related Articles Simultaneous measurement of acalabrutinib, ibrutinib, and their metabolites in beagle dog plasma by UPLC-MS/MS and its application to a pharmacokinetic study. J Pharm...
Latest News

ADC Therapeutics gibt Dosierung des ersten Patienten im zulassungsrelevanten Phase-II-Teil der klinischen Studie LOTIS 3 von Loncastuximab-Tesirin (Lonca) in Kombination mit Ibrutinib bekannt

Newsemia
LAUSANNE (Schweiz)–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT), ein im Bereich der späten klinischen Forschung tätiges Biotechnologieunternehmen mit Schwerpunkt auf Onkologie, das Vorreiter bei der Entwicklung...
Pharma / Biotech

Extrahepatic metabolism of ibrutinib.

Newsemia
Extrahepatic metabolism of ibrutinib. Invest New Drugs. 2020 Jul 04;: Authors: Rood JJM, Jamalpoor A, van Hoppe S, van Haren MJ, Wasmann RE, Janssen MJ,...
Latest News

Janssen busca ampliar el uso de IMBRUVICA® (ibrutinib) en combinación con rituximab para pacientes con leucemia linfocítica crónica (LLC) no tratada con anterioridad

Newsemia
BEERSE, Bélgica–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson ha anunciado hoy la presentación de una solicitud de variación de Tipo II a la...
Latest News

X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor in Combination with Ibrutinib for the Treatment of Waldenström’s Macroglobulinemia (WM)

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today...
Pharma / Biotech

Itraconazole increases ibrutinib exposure ten-fold and reduces inter-individual variation – A potentially beneficial drug-drug interaction.

Newsemia
Related Articles Itraconazole increases ibrutinib exposure ten-fold and reduces inter-individual variation – A potentially beneficial drug-drug interaction. Clin Transl Sci. 2019 Oct 30;: Authors: Tapaninen...
Pharma / Biotech

A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC-ESI-MS/MS: validation and application to pharmacokinetic studies of a novel ibrutinib nanocrystalline.

Newsemia
Related Articles A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC-ESI-MS/MS: validation and application to pharmacokinetic studies of a novel...
Neurology

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network.

Newsemia
Related Articles Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy